Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Jul 27, 2026
Why Is Calumet (CLMT) Stock Down -2.64% Today?

Why Is Calumet (CLMT) Stock Down -2.64% Today?

Key Takeaways

  • Calumet shares fell 2.64% on Friday, closing at $41.69, extending a two-day losing streak that has erased roughly 5.5% from the stock's value since Wednesday's close.
  • Profit-taking was the primary catalyst, as traders locked in gains following a blistering rally that saw the stock surge more than 109% year-to-date and touch a 52-week high of $45.20 intraday on Thursday.
  • Valuation concerns weighed on sentiment, with multiple analysts flagging the stock as overvalued relative to a widely cited fair value estimate of $38.80 amid thin margins and high leverage.
  • Broader market and energy-sector headwinds compounded the selling pressure, as crude oil prices retreated more than 4% on Friday and technology stocks dragged major indices lower.
  • Traders are now watching the upcoming Q2 earnings report scheduled for August 7 for clarity on operational momentum and the company's deleveraging progress.

Opening Summary

CLMT, the stock of Calumet, Inc. — an Indianapolis-based manufacturer and marketer of specialty branded products and renewable fuels — fell 2.64% in Friday's trading session, closing at $41.69, down $1.13 from the prior session's close of $42.82. The decline marked the second consecutive day of selling pressure after the stock hit a fresh 52-week high of $45.20 during Thursday's intraday trading, representing a sharp reversal from the euphoric rally that has propelled shares more than 109% higher year-to-date.

Profit-Taking After a Massive Rally

The most immediate driver behind the decline was straightforward profit-taking. CLMT has been one of the standout performers in the specialty chemicals and renewable fuels space this year, with shares rocketing from a 52-week low of $12.94 to as high as $45.20 — a gain of roughly 249%. Much of that enthusiasm was fueled by Calumet's early-July redemption of $100 million in 9.75% Senior Notes due 2028, a move that reinforced the company's commitment to deleveraging its heavily indebted balance sheet. Additionally, the MaxSAF 150 sustainable aviation fuel expansion project at its Montana Renewables subsidiary has captured investor imagination, promising to position Calumet as a key player in the fast-growing SAF market.

With those catalysts now largely priced in, traders used the mid-session Thursday reversal at the $45 level as a signal to lock in profits. Friday's session saw continued distribution, with volume of 1.42 million shares well above the average of roughly 983,000, indicating that institutional and retail sellers alike participated in the move.

Valuation Scrutiny and Fundamental Headwinds

Behind the selling sits a growing chorus of skepticism about Calumet's valuation. The stock's sharp ascent pushed its forward price-to-earnings multiple to approximately 61x, a demanding level for a company that reported a Q1 2026 net loss of $317 million — equivalent to earnings per share of negative $3.64, which badly missed analyst estimates of negative $0.57. The company's gross margins remain thin at roughly 7.4%, and its net debt-to-EBITDA ratio hovers around 7x, leaving limited room for error. With a consensus analyst price target of approximately $36.75 — representing a potential downside of roughly 12% from Friday's close — the market appears to be reassessing whether the growth story can justify the premium.

Broader Energy and Market Context

Calumet's decline did not occur in isolation. Crude oil prices tumbled more than 4% on Friday, with Brent retreating from above $100 per barrel to around $96, as traders booked profits from the week's geopolitical rally and reports emerged that China had initiated efforts to resume stalled peace talks between the United States and Iran. The pullback in crude weighed broadly on energy-linked equities, even as the sector had posted strong weekly gains. Meanwhile, U.S. equity markets struggled with their own crosscurrents: the S&P 500 finished essentially flat on Friday, but the Nasdaq Composite shed 0.64% as concerns over escalating AI capital expenditures continued to rattle technology stocks. The Dow Jones Industrial Average managed a 0.46% gain, but all three major indices closed the week in the red.

New tariffs imposed by the Trump administration on goods from 60 trading partners, combined with lingering anxiety over Middle East supply disruptions, created a risk-off undercurrent that likely accelerated profit-taking in high-momentum names like CLMT.

Market Context and Trading Activity

Friday's selloff was notable for its elevated volume, which came in roughly 45% above the 20-day average. The stock opened at $42.63, briefly pushed to an intraday high of $43.00, but ultimately slid to a session low of $41.17 before settling at $41.69. After-hours trading saw further erosion to $41.21, suggesting that selling pressure had not fully abated by the closing bell. Technically, the breach below $42 — a level that had served as support during the late-July consolidation — raises the possibility of a test of the 50-day moving average, which sits near $34. More broadly, CLMT remains well above its 200-day moving average of approximately $26.24, underscoring that the current pullback, while sharp, has not yet threatened the longer-term uptrend.

What Comes Next for CLMT

All eyes now turn to Calumet's second-quarter earnings report, scheduled for August 7, 2026. Investors will be scrutinizing whether the operational improvements flagged by management — including the restart of the Shreveport facility and the commencement of MaxSAF 150 operations — translated into improved cash flow and margin performance. The Q1 earnings call had framed the massive $317 million net loss as largely driven by non-cash mark-to-market items and RINs (Renewable Identification Numbers) adjustments, but bulls will need to see concrete evidence of progress on the bottom line to rekindle upward momentum.

Key risks include continued volatility in crude oil prices and refining margins, potential shifts in renewable fuel policy that could impact SAF economics, and the persistent challenge of a $2.3 billion long-term debt load against deeply negative shareholder equity. On the other hand, if crack spreads remain elevated and the specialty products segment continues to execute on its pricing strategy, the deleveraging narrative could regain traction. For now, the stock appears to be in a consolidation phase as the market digests the magnitude of its year-to-date gains.

Trending AI Robots

For traders seeking data-driven approaches to navigate volatile markets like the one affecting CLMT, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots. Tickeron provides hundreds of algorithmic trading bots covering thousands of tickers across multiple strategies, timeframes, and performance metrics, but only the strongest performers under current market conditions are featured in this dedicated section. Bots vary by strategy type — from swing trading to trend following to pattern recognition — enabling traders to identify automated approaches aligned with their risk tolerance and market outlook. Explore the Trending AI Robots page to discover which algorithms are generating the most compelling signals right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CLMT

Momentum Indicator for CLMT turns positive, indicating new upward trend

CLMT saw its Momentum Indicator move above the 0 level on June 26, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 78 similar instances where the indicator turned positive. In of the 78 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CLMT just turned positive on June 29, 2026. Looking at past instances where CLMT's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

CLMT moved above its 50-day moving average on June 25, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CLMT crossed bullishly above the 50-day moving average on June 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CLMT advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 232 cases where CLMT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CLMT moved out of overbought territory on July 24, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator moved out of overbought territory. In of the 46 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where CLMT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLMT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CLMT broke above its upper Bollinger Band on July 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CLMT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (7.177). P/E Ratio (27.068) is within average values for comparable stocks, (43.557). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (72.199). CLMT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.021). P/S Ratio (0.868) is also within normal values, averaging (69.593).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 12.05B. The market cap for tickers in the group ranges from 47 to 236.85B. LIN holds the highest valuation in this group at 236.85B. The lowest valued company is GTBT at 47.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was -2%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 5%. MNTK experienced the highest price growth at 19%, while YMAT experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was -8%. For the same stocks of the Industry, the average monthly volume growth was -30% and the average quarterly volume growth was -48%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 56
Price Growth Rating: 54
SMR Rating: 79
Profit Risk Rating: 82
Seasonality Score: 6 (-100 ... +100)
View a ticker or compare two or three
CLMT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a producer of specialty hydrocarbon products

Industry ChemicalsSpecialty

Profile
Details
Industry
Industrial Specialties
Address
1060 N Capitol Avenue
Phone
+1 317 328-5660
Employees
1540
Web
https://www.calumet.com
Interact to see
Advertisement
Citigroup (C) is set to report Q4 2025 earnings on January 14, 2026, making it the immediate catalyst in this comparison. HSBC Holdings (HSBC) will release its Full-Year 2025 results on February 25, 2026, positioning it as a medium-term earnings event.
Wells Fargo’s quarterly results carry broader significance because the bank serves as a key indicator of U.S. consumer and commercial banking conditions. Its earnings often influence sentiment toward the entire large-cap banking sector. After a stretch of improved market conditions and stronger capital markets activity, investors are looking for confirmation that profit momentum is sustainable rather than driven by a single favorable quarter.
M&T Bank (MTB) is expected to deliver Q4 2025 EPS of $4.44–$4.46, representing roughly 13% year-over-year growth, driven by improving net interest income as funding costs decline. PNC Financial Services Group (PNC) is projected to post Q4 EPS of $4.19–$4.23, supported by about 1.5% sequential NII growth from rate relief and steady loan demand. U.S. Bancorp (USB) is forecast to earn $1.19 per share, an 11.2% annual increase, with revenues estimated at $7.33 billion, up 5%.
Dash (DASH.X) has ignited the crypto market with a powerful mid-January 2026 breakout, rallying more than 125% in a single week and decisively outperforming fellow privacy coins such as Monero and Zcash. The surge was fueled by a sharp short squeeze that wiped out nearly $4.9 million in bearish positions, alongside a major catalyst: Dash’s integration with Alchemy Pay, enabling direct fiat purchases across 173 countries.
The Schwab U.S. Small-Cap ETF (SCHA) is holding firm near the $28 level as 2026 begins, even as broader markets remain volatile. While short-term price action has been uneven, underlying signals suggest the ETF may be setting up for a meaningful breakout as interest-rate cuts revive small-cap equities. Technical models highlight an unusually favorable risk-reward profile—up to 22:1—with long-term momentum strengthening despite near-term consolidation.
Prologis (PLD), the world’s largest logistics-focused REIT, reported fourth-quarter and full-year 2025 earnings on January 21, 2026, capping a standout year for the industrial real estate sector. Demand for modern logistics facilities remains elevated as e-commerce expansion and supply chain reconfiguration continue to reshape global distribution networks.
The Travelers Companies, Inc.(TRV), a major player in the property and casualty insurance market, reported fourth-quarter 2025 results on January 21, 2026, closing out a year marked by underwriting discipline despite volatile weather activity and pricing pressures. The results underscore Travelers’ ability to generate strong profitability while navigating challenges in personal insurance lines and heightened catastrophe risk.
FingerMotion, Inc. (NASDAQ: FNGR) reported fiscal third-quarter 2026 results on January 15, 2026, triggering a sharp selloff as investors reacted to a steep revenue decline and widening losses. Shares fell roughly 32% following the release after the mobile services provider disclosed a 32% year-over-year drop in revenue and a net loss of $1.67 million for the quarter ended November 30, 2025.
CSX Corporation, a major U.S. East Coast rail operator, reports fourth-quarter 2025 earnings after market close today, marking the end of a year characterized by uneven freight recovery. Comparing CSX with Canadian Pacific Kansas City (CP), now a transcontinental operator following its 2023 merger, highlights contrasting strategies within the North American rail sector.
Procter & Gamble (PG) reports fiscal Q2 2026 earnings on January 22, with consensus expecting modest revenue growth amid commodity and tariff pressures. EPS is forecast at ~$1.87, slightly below last year’s $1.88. Colgate-Palmolive (CL) is set to release Q4 2025 earnings on January 30, while Unilever (UL) reports full-year 2025 results on February 12.
CSX (NASDAQ: CSX) reports Q4 2025 earnings after market close on January 22, 2026, with consensus EPS ~$0.42 and revenue ~$3.57 billion. Union Pacific (NYSE: UNP) follows on January 27, with EPS expected near $2.89 and revenue around $6.15 billion. Norfolk Southern (NYSE: NSC) closes the week on January 29, with consensus EPS ~$2.77.
The SPDR S&P Aerospace & Defense ETF (XAR) has surged to a new 52-week high above $281 this week, climbing 21% month-to-date and 20% year-to-date through January 2026. The rally, driven by robust sector momentum and a clean technical breakout, is outpacing broader indices like the S&P 500. XAR’s equal-weighted structure amplifies gains from top aerospace and defense holdings in missiles, aircraft, and space systems, attracting significant trader and institutional attention amid heightened geopolitical tensions.
The iShares U.S. Aerospace & Defense ETF (ITA) continues to attract trader attention, building on a remarkable 47.7% gain in 2025 amid rising defense budgets and heightened global security concerns. The ETF is approaching all-time highs, with top holdings such as GE Aerospace and RTX Corporation driving the rally. Traders are adding positions on dips while monitoring confirmation above key resistance levels near recent peaks, anticipating a potential technical breakout.
ProShares Ultra Gold (UGL), the leveraged ETF designed to deliver 2× the daily performance of gold futures, has climbed sharply this week as gold prices continue near historic levels. The ETF’s move reflects renewed inflows into gold-related products and heightened investor interest in safe-haven assets amid ongoing geopolitical and macroeconomic uncertainty. UGL’s price action closely mirrors the strong trend in gold futures, attracting short-term momentum trading even as the leveraged structure carries heightened risk.
Hubbell Incorporated (HUBB) reached an all-time high of $485.91 this week, reflecting strong buying interest in the industrial sector. The breakout comes amid mixed institutional activity—some funds trimming positions while others add new stakes—highlighting investor focus on HUBB’s multi-year rally.
Chevron’s upcoming Q4 report highlights its first full quarters integrating Hess, following record Q3 production of 4.1 million barrels of oil equivalent per day (MMboe/d). Comparing CVX with ExxonMobil and Shell provides insight into how each supermajor is navigating a volatile oil market with prices hovering below $60 per barrel.
SoFi Technologies is set to report Q4 and full-year 2025 earnings on January 30, 2026, closing out a pivotal year for the digital finance platform. With its fiscal year ending December 31, the report follows a strong Q3 that featured record net revenue of $962 million and member growth to 12.6 million, a 35% year-over-year increase.
ASML reported Q4 2025 net sales of $9.7 billion, gross margin of 52.2%, net income of $2.8 billion, and record net bookings of $13.2 billion, including $7.4 billion in EUV orders.
IDEXX Laboratories (IDXX) reports Q4 2025 earnings on February 2, 2026, with analysts expecting continued strength in recurring revenue from companion animal diagnostics. Danaher (DHR) reports on January 28, while Thermo Fisher Scientific (TMO) follows in early February, with both facing low-single-digit core growth expectations across life sciences and diagnostics.
NIO Inc. (NIO) produced its one-millionth vehicle this week at its Hefei facility, closing out a record 2025 delivery total of 326,028 units, up 46.9% year over year. The milestone, announced January 6, reflects accelerating demand for core models such as the ES8 SUV and newer brands ONVO and Firefly.
Why Is Calumet (CLMT) Stock Down -2.64% Today?